Abstract
BackgroundAbomasal ulceration is recognized in neonatal and adult cattle, but research regarding treatment is limited. Histamine‐2 receptor antagonists (H2RA), such as famotidine, are used clinically with little evidence‐based research about efficacy in adult cattle.Hypothesis and ObjectivesIntravenous famotidine administered at 0.4 mg/kg will increase the pH of abomasal outflow digesta compared to saline control in adult cattle. The objectives were to assess the effect of famotidine, administered as a single dose and as multiple doses, on abomasal outflow fluid pH in adult cattle. A third objective was to describe the pharmacokinetic parameters of IV famotidine in cattle.AnimalsFour clinically healthy adult Angus‐cross steers previously fitted with duodenal cannulae placed orad to the biliary and pancreatic ducts.MethodsRandomized, 2‐way cross‐over clinical trial. Steers received IV famotidine (0.4 mg/kg) as a single and 3‐dose regimen (every 8 hours) versus saline control. Blood for analysis of serum famotidine concentration was collected intermittently for 12 hours, and abomasal outflow fluid pH was measured at intervals for a 24‐hour period. After a 34‐hour washout period, the opposite treatments were administered and the sampling repeated.ResultsAbomasal outflow fluid pH was higher in steers treated with famotidine for up to 4 hours after a single dose but the effect decreased with subsequent doses. The median (range) elimination half‐life was 3.33 (3.21‐3.54) hours.Conclusions and Clinical ImportanceFamotidine may be useful for treatment or prevention of abomasal ulceration in adult cattle, but the duration of effect may decrease with time.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.